Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%), etc.
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily
Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%), etc.
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie
Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(8.5%),BML Investment Partners, L.P.(7.9%)
Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.7%),Peter Kolchinsky(47.7%), etc.
Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Tate Simon
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ratcliffe Liam
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dunn Judith
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rosenberg Adam Joseph
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Executive Chairman Levin Andrew David
Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(48.8%),Peter Kolchinsky(48.8%), etc.
Eliem Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Accounting Officer Pimblett Emily
Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie
Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Intermediate Capital Investments Limited(7.5%),Intermediate Capital Group plc(7.5%)
Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Samlyn Capital, LLC(0%),Samlyn, LP(0%), etc.
Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(7.1%),BML Investment Partners, L.P.(6.9%)
No Data